Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia

被引:39
作者
Liu, Dongping [2 ]
He, Qingjuan [2 ,3 ]
Liu, Caigang [1 ]
机构
[1] China Medial Univ, Affiliated Hosp 1, Dept Oncol, Breast Surg Ward, Shenyang 110001, Liaoning, Peoples R China
[2] China Medial Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China
[3] Eighth Peoples Hosp Qindao, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China
关键词
cyclooxygenase-2; dysplasia; Helicobacter pylori; intestinal metaplasia; vascular endothelial growth factor; CANCER; PATHWAY; ASSOCIATION;
D O I
10.1111/j.1440-1746.2009.06168.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: To examine the rate of Helicobacter pylori infection and the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in gastric mucosa with intestinal metaplasia or dysplasia, and explore their correlations in precancerous gastric lesions. Methods: A total of 172 patients were included in the study. H. pylori infection was evaluated by hematoxylin-eosin and modified Giemsa staining. The expression of COX-2 and VEGF proteins was detected by immunohistochemistry. Results: The rates of H. pylori infection in gastric mucosal dysplasia (DYS), intestinal metaplasia in gastric mucosa (IM), chronic atrophic gastritis (CAG) and chronic superficial gastritis (CSG) patients were significant differences (P = 0.001). The average optical density (AOD) values of COX-2 staining in CSG, CAG, IM and DYS patients were 13.81 +/- 5.53, 45.28 +/- 21.44, 73.67 +/- 26.02 and 91.23 +/- 45.11, respectively, with significant differences among CSG, CAG and IM patients (P = 0.037, 0.001 and 0.047 for CSG vs CAG, CSG vs IM and CAG vs IM, respectively). The expression level of VEGF in DYS patients was significantly higher than those in other patients (P = 0.001, 0.001 and 0.001 for DYS vs CSG, DYS vs CAG and DYS vs IM, respectively). The expression levels of COX-2 in H. pylori-positive IM, CAG and DYS patients were significantly higher than those in H. pylori-negative counterparts (P = 0.043, 0.009, 0.001, respectively). Additionally, the expression level of COX-2 was positively correlated with that of VEGF with the aggravation of gastric mucosal lesions (r = 0.640, P = 0.006). Conclusion: H. pylori infection might be able to induce the expression of COX-2 in precancerous gastric lesions, which in turn upregulates the expression of VEGF.
引用
收藏
页码:795 / 799
页数:5
相关论文
共 13 条
[1]   Gastric cancer: epidemiology, pathology and treatment [J].
Alberts, SR ;
Cervantes, A ;
van de Velde, CJH .
ANNALS OF ONCOLOGY, 2003, 14 :31-36
[2]   Association of Helicobacter pylori infection with gastric cancer [J].
Alexander, GA ;
Brawley, OW .
MILITARY MEDICINE, 2000, 165 (01) :21-28
[3]   Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype:: A potential pathway to cancer? [J].
Farinati, F ;
Cardin, R ;
Russo, VM ;
Busatto, G ;
Franco, M ;
Rugge, M .
HELICOBACTER, 2003, 8 (03) :227-234
[4]   Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer [J].
Guo, XL ;
Wang, LE ;
Du, SY ;
Fan, CL ;
Li, L ;
Wang, P ;
Yuan, Y .
WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (02) :246-249
[5]   The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells [J].
Iwamoto, Jun-ichi ;
Mizokami, Yuji ;
Takahashi, Kimiko ;
Matsuoka, Takeshi ;
Matsuzaki, Yasushi .
HELICOBACTER, 2008, 13 (03) :174-182
[6]  
Majid M A, 2009, Bangladesh Med Res Counc Bull, V35, P7
[7]  
Mitsuhashi J, 2004, HEPATO-GASTROENTEROL, V51, P1636
[8]  
Saukkonen K, 2001, CLIN CANCER RES, V7, P1923
[9]   The Vienna classification of gastrointestinal epithelial neoplasia [J].
Schlemper, RJ ;
Riddell, RH ;
Kato, Y ;
Borchard, F ;
Cooper, HS ;
Dawsey, SM ;
Dixon, MF ;
Fenoglio-Preiser, CM ;
Fléjou, JF ;
Geboes, K ;
Hattori, T ;
Hirota, T ;
Itabashi, M ;
Iwafuchi, M ;
Iwashita, A ;
Kim, YI ;
Kirchner, T ;
Klimpfinger, M ;
Koike, M ;
Lauwers, GY ;
Lewin, KJ ;
Oberhuber, G ;
Offner, F ;
Price, AB ;
Rubio, CA ;
Shimizu, M ;
Shimoda, T ;
Sipponen, P ;
Solcia, E ;
Stolte, M ;
Watanabe, H ;
Yamabe, H .
GUT, 2000, 47 (02) :251-255
[10]   Regulation of glucose metabolism-related genes and VEGF by HIF-1α and HIF-1β, but not HIF-2α, in gastric cancer [J].
Song, In-Sung ;
Wang, Ai-Guo ;
Yoon, Sun Young ;
Kim, Jeong-Min ;
Kim, Joo Heon ;
Lee, Dong-Seok ;
Kim, Nam-Soon .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2009, 41 (01) :51-58